Full List Of Stories
AstraZeneca drug cuts lung cancer deaths by nearly a third
A clinical study has shown AstraZeneca’s immunotherapy drug Imfinzi to have reduced the risk of death in patients with mid-stage lung cancer by nearly a third in a clinical study.
FTSE 250 movers: Travel back in the sun, Plus500 hit by read-across
London's FTSE 250 was even at 20,506. 16 in afternoon trade on Tuesday.
Michael Kors strides into European luxury market with $2.1bn Versace takeover
US fashion giant Michael Kors confirmed a $2. 1bn takeover of Italian high-end fashion house Versace on Tuesday, giving the former a route into the European luxury fashion market.
Keystone Law exceeds expectations as UK growth strategy excels
Legal firm Keystone Law saw its shares jump on Tuesday after strong first-half revenue and profit growth saw trading exceed expectations.
Amerisur tumbles after 'disappointing' lack of potential at Colombian target
Oil and gas company Amerisur Resources saw its shares fall on Tuesday after the firm revealed that its main target in Colombia has no oil producing potential.
WANdisco interim losses grow as order drop
Distributed computing firm WANdisco reported a drop in first-half revenues that saw the business’ losses deepen, with news of a large auto industry contract not enough to stop its shares dipping on Tuesday.
Hotel Chocolat's profits sweeten as worldwide expansion targeted
Chocolatier and cocoa grower Hotel Chocolat on Tuesday reported a jump in first-half profits and set its sights on expansion into Scandinavia, Japan and the US.